We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Admission Glucose ICU Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00569322
First Posted: December 7, 2007
Last Update Posted: November 26, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
HealthPartners Institute
  Purpose
Determine if routine BG testing at the time of ICU admission is being done on all patients, irrespective of a prior diagnosis of diabetes mellitus, and whether it provides clinically important information.

Condition Intervention
Hyperglycemia Procedure: BG Test

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Admission Blood Glucose Levels in the Intensive Care Unit

Resource links provided by NLM:


Further study details as provided by HealthPartners Institute:

Study Start Date: December 2003
Study Completion Date: September 2004
Detailed Description:

This prospective, observational study was performed in the medical-surgical ICU of a single hospital within a large multi-specialty healthcare system.

It was determined that it was not standard care to do glucose testing on all patients admitted to medical/surgical ICU's who did not have diagnosed diabetes and varied widely with the admitting service.

The primary objective of the study was to assess the availability and clinical value of blood glucose testing at the time of ICU admission after testing was implemented as routine care in the ICU.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • ICU Admission

Exclusion Criteria:

  • < 18 years of age
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00569322


Locations
United States, Minnesota
Methodist Hospital - Park Nicollet Health Services
Minneapolis, Minnesota, United States, 55416
Sponsors and Collaborators
HealthPartners Institute
Investigators
Principal Investigator: Lisa H Fish, MD International Diabetes Center - Park Nicollet Health Services
  More Information

ClinicalTrials.gov Identifier: NCT00569322     History of Changes
Other Study ID Numbers: 01817-03-C
First Submitted: December 5, 2007
First Posted: December 7, 2007
Last Update Posted: November 26, 2015
Last Verified: September 2007

Keywords provided by HealthPartners Institute:
ICU
Admission
BG

Additional relevant MeSH terms:
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases